Published in Curr Drug Metab on June 01, 2008
Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside. Pharmacol Ther (2012) 0.92
Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy. Eur J Clin Pharmacol (2010) 0.86
Role of aripiprazole in treatment-resistant schizophrenia. Neuropsychiatr Dis Treat (2012) 0.82
Effect of aripiprazole on cognitive function and hyperprolactinemia in patients with schizophrenia treated with risperidone. Clin Psychopharmacol Neurosci (2013) 0.80
Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites. Int J Mol Sci (2012) 0.79
The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study. Neuropsychiatr Dis Treat (2014) 0.78
Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice. Acta Pharmacol Sin (2011) 0.78
Effect of combination of aripiprazole with carbamazepine and fluvoxamine on liver functions in experimental animals. Indian J Pharmacol (2013) 0.77
Severe potential drug-drug interactions in older adults with dementia and associated factors. Clinics (Sao Paulo) (2016) 0.77
Genetic Determinants of Clozapine-Induced Metabolic Side Effects. Can J Psychiatry (2016) 0.75
Evaluation of anxiolytic effects of aripiprazole and hydroxyzine as a combination in mice. J Basic Clin Pharm (2016) 0.75
Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatment. PLoS One (2012) 0.75
Parkinsonism secondary to duloxetine use: a case report. North Clin Istanb (2015) 0.75
Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity. World J Gastrointest Pharmacol Ther (2017) 0.75
Effects of suberoylanilide hydroxamic acid on rat cytochrome P450 enzyme activities. Int J Clin Exp Pathol (2015) 0.75
Prescribing clozapine and rifampicin: clinical impact of their interaction. BJPsych Bull (2016) 0.75
The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions. Neuropsychopharmacology (2017) 0.75
Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis. Ann Intern Med (2012) 2.52
Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ (2006) 2.09
Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology (2002) 1.72
Financial effect of a hospital outpatient senior clinic on an academic medical center. J Am Geriatr Soc (2002) 1.58
The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med (2005) 1.54
MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB J (2010) 1.39
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol (2012) 1.19
Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation. Health Qual Life Outcomes (2008) 1.19
Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study. Crit Care Med (2003) 1.16
Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain Res (2006) 1.03
Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results. Hum Psychopharmacol (2005) 0.98
Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biol Psychiatry (2007) 0.98
Noradrenergic and serotonergic neuroendocrine responses in prepubertal, peripubertal, and postpubertal rats pretreated with desipramine and sertraline. J Am Acad Child Adolesc Psychiatry (2002) 0.92
Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients. Ther Adv Psychopharmacol (2012) 0.90
Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex. J Neurosci (2009) 0.89
Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder. Psychiatry Res (2005) 0.88
Suicide methods from the internet. Am J Psychiatry (2004) 0.87
The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders. Cell Mol Neurobiol (2007) 0.87
Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients. Neuropsychopharmacology (2006) 0.87
Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs. Ann Med (2002) 0.87
Role of progesterone and other neuroactive steroids in anxiety disorders. Expert Rev Neurother (2004) 0.84
GABAergic neurosteroids: the "endogenous benzodiazepines" of acute liver failure. Neurochem Int (2011) 0.82
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychopharmacol (2009) 0.80
Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. Biol Psychiatry (2008) 0.80
Supportive text messages to reduce mood symptoms and problem drinking in patients with primary depression or alcohol use disorder: protocol for an implementation research study. JMIR Res Protoc (2015) 0.79
Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action. Neuroreport (2002) 0.79
Optimizing antidepressant treatment: efficacy and tolerability. Int Clin Psychopharmacol (2002) 0.79
Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6-[18F]-L-m-tyrosine. Synapse (2004) 0.79
Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes. J Neurosci Res (2014) 0.78
The relation between peripheral and central glutamate and glutamine in healthy male volunteers. J Psychiatry Neurosci (2006) 0.78
A Critical Review of Neurobiological Factors Involved in the Interactions Between Chronic Pain, Depression, and Sleep Disruption. Clin J Pain (2016) 0.77
Involvement of Neuroactive Steroids in Pain, Depression and Anxiety. Mod Trends Pharmacopsychiatri (2015) 0.77
Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia. Rev Bras Psiquiatr (2011) 0.76
Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis. Neurochem Int (2007) 0.76
Antipsychotics in adults with schizophrenia: does sponsorship of research articles affect the findings? In response. Ann Intern Med (2013) 0.75
Vitamin D for mental health and cognition. CMAJ (2010) 0.75
Re: Treatment of perinatal mood and anxiety disorders: a review. Can J Psychiatry (2008) 0.75
Antidepressants: From MAOIs to SSRIs and more. Indian J Psychiatry (2011) 0.75
Chirality and drugs used to treat psychiatric disorders. J Psychiatry Neurosci (2002) 0.75
An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia. J Psychopharmacol (2005) 0.75
Expanded newborn screening in Arkansas: a program of the Arkansas Department of Health. J Ark Med Soc (2008) 0.75
Challenges in advancing mental and physical health of patients with serious mental illness. J Psychopharmacol (2005) 0.75
Biogenic Amines and the Amino Acids GABA and Glutamate: Relationships with Pain and Depression. Mod Trends Pharmacopsychiatri (2015) 0.75
Hypoplastic splenium of the corpus callosum and co-occurrence of attention deficit/hyperactivity and language disorders: a case report. Rev Bras Psiquiatr (2012) 0.75
New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systems. Rev Bras Psiquiatr (2010) 0.75
Pharmacological management of bipolar depression. Acta Psychiatr Scand (2002) 0.75